QUILT-3.080: NANT Pancreatic Cancer Vaccine

NCT03586869 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention

Conditions

Pancreatic Cancer

Interventions

DRUG: Aldoxorubicin HCl
BIOLOGICAL: ALT-803
BIOLOGICAL: ETBX-011
BIOLOGICAL: ETBX-021
BIOLOGICAL: ETBX-051
BIOLOGICAL: ETBX-061
BIOLOGICAL: GI-4000
BIOLOGICAL: GI-6207
BIOLOGICAL: GI-6301
BIOLOGICAL: haNK for infusion
BIOLOGICAL: bevacizumab
DRUG: Capecitabine
DRUG: Cyclophosphamide
DRUG: Fluorouracil
DRUG: Leucovorin
DRUG: nab-Paclitaxel
DRUG: Oxaliplatin
BIOLOGICAL: Avelumab
PROCEDURE: SBRT

Sponsor

ImmunityBio, Inc.